SubscribeDIA will host its 18th Annual EuroMeeting March 6-8, 2006 at Le Palais des Congrès in Paris. The program will address the latest developments in important European initiatives, including pediatrics, advanced therapies, the technology platform, pharmacogenomics, pharmacovigilance and risk management planning.
With a bold agenda, including sessions on the revised Pharmaceutical Legislation, the 18th Annual DIA EuroMeeting is a ‘not to miss’ event,” said David Maola, executive director of DIA. “The meeting will address a multitude of issues that will help improve the lives of people around the world.
The 18th Annual EuroMeeting will feature over 140 exhibits and 350 speakers presenting on topics organized into 17 session tracks:
- Innovation and Competitiveness in Global Medicines Development
- R & D – Are There New Molecular and Nonclinical Paradigms?
- Advanced Therapies in Biologics
- Promises and Realities of Pharmacogenomics and New Technologies
- Clinical Research – European Focus versus Global and Development Constraints
- Investigational Clinical Research
- Challenges of the Revised Pharma Regulatory Environment
- The Patient’s Voice in Europe
- Medical Information
- Statistics
- Data Management
- Global Pharmacovigilance and Risk Management
- Quality and Quality Systems – GCP and GMP Issues
- Project Management – Outsourcing and Alliances
- Bringing Authorized Medicines to the Market – New Challenges
- Generics and OTC
Fourteen tutorials, led by a variety of skilled professionals, will also be offered at the event. These tutorials will take place on Monday, March 6, from 9:00 a.m. - 12:30 p.m.
For more information on DIA’s 18th Annual EuroMeeting, please download the brochure at http://www.diahome.org/Content/Events/06101.pdf.
Please visit http://www.diahome.org/docs/events/events_search_detail.cfm?EventID=06101to register online.
Basel, Switzerland - September X, 2005